Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Gene Activated Human Glucocerebrosidase----[1] 19
2Gene activated human glucocerebrosidase, velaglucerase alfa[1] Velaglucerase alfa[1] D09029 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
3Gene-Activated Human Glucocerebrosidase----[1] 19
4Gene-Activated Human Glucocerebrosidase 200U/vial----[1] 19
5Gene-Activated Human Glucocerebrosidase 400U/vial----[1] 19
6GLUCOCEREBROSIDASE----[1] 19
7GLUCOCEREBROSIDASE UMANO GENE-ATTIVATO----[1] 19
8Human Glucocerebrosidase (prGCD)[1] Taliglucerase alfa[1] D09675 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
9Human glucocerebrosidase cDNA----[1] 19
10Human glucocerebrosidase gene into autologous peripheral blood stem cells----[1] 19
11Plant cell expressed recombinant glucocerebrosidase (prGCD)[1] Taliglucerase alfa[1] D09675 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
12Plant Cell Recombinant Glucocerebrosidase----[1] 19
13Recombinant human derived macrophage-targeted beta-Glucocerebrosidase----[1] 19
14Recombinant human derived macrophage-targeted ß-Glucocerebrosidase----[1] 19
15Recombinant human glucocerebrosidase----[1] 19
16Recombinant Human Glucocerebrosidase (prGCD)[1] Taliglucerase alfa[1] D09675 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19
17Taliglucerase alfa - Recombinant human glucocerebrosidase[1] Taliglucerase alfa[1] D09675 [1] GBA1 💬[4] Lysosome, Metabolic pathways, Other glycan degradation, Sphingolipid metabolism 💬[1] 19